LEIDEN JEFFREY M — SEC Form 4 filings

SEC reporting owner CIK 1242825. 16 Form 4 filings on record with FilingPulse; latest filed 2026-05-11.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2024-01-10 to 2026-05-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman, Director1524 legs · 159,909 sh · $70,816,48224
Odyssey Therapeutics, Inc. (ODTX)Director11 leg · 5,000 sh · $100,0008

Form 4 filings — LEIDEN JEFFREY M

FiledFormIssuerReported transactionsSource
2026-05-114Odyssey Therapeutics, Inc. (ODTX)Purchase (P): 5,000 @ $20 · Conversion (C): 28,698 · Option exercise (M): 2,963 · Tax withholding (F): 17 @ $18 · Conversion (C): 79,166 (derivative) · Conversion (C): 100,000 (derivative) · +3 moreEDGAR
2026-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 3,547 @ $485.11EDGAR
2026-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 8,269 @ $0 · Tax withholding (F): 2,964 @ $483.75EDGAR
2026-01-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 9,012 @ $0EDGAR
2025-12-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 63,781 @ $86.52 · Sale (S): 4,469 @ $440.40 · Sale (S): 1,320 @ $441.26 · Sale (S): 2,469 @ $443.21 · Sale (S): 4,352 @ $444.36 · Sale (S): 7,899 @ $445.56 · +10 moreEDGAR
2025-11-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 19,688 @ $91.05 · Sale (S): 18,528 @ $440.22 · Sale (S): 1,160 @ $441.05 · Option exercise (M): 13,835 @ $91.05 · Option exercise (M): 39,769 @ $86.52 · Sale (S): 32,234 @ $440.30 · +5 moreEDGAR
2025-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 6,066 @ $463.46EDGAR
2025-02-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 7,209 @ $0 · Tax withholding (F): 2,525 @ $450.83EDGAR
2025-02-064VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 15,414 @ $0EDGAR
2024-09-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 3,784 @ $499EDGAR
2024-02-214VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 4,118 @ $420.58EDGAR
2024-02-164VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 4,356 @ $419.04 · Sale (S): 4,655 @ $419.16EDGAR
2024-02-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 2,009 @ $419.22 · Sale (S): 647 @ $420.39 · Sale (S): 737 @ $419.13EDGAR
2024-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,698 @ $421.73 · Tax withholding (F): 8,048 @ $422.74EDGAR
2024-02-084VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 10,464 @ $0 · Grant/award (A): 20,452 @ $0 · Grant/award (A): 7,707 @ $0EDGAR
2024-01-104VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 6,648 @ $419.07EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1242825 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →